Basic information
- Name:
Methanone,(2-butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]-,hydrochloride (1:1)
- Superlist Name:
- Amiodarone hydrochloride
- CAS No.:
19774-82-4
- Molecular Structure:
![Molecular Structure of 19774-82-4 (Methanone,(2-butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]-,hydrochloride (1:1))](http://www.lookchem.com/300w/2010/0619/19774-82-4.jpg)
- Formula:
- C25H30ClI2NO3
- Molecular Weight:
- 681.78
- Synonyms:
- Ketone,2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl,hydrochloride (7CI,8CI);Methanone,(2-butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]-,hydrochloride (9CI);2-Butyl-3-benzofuranyl4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl ketone hydrochloride;Amiodar;Amiodaronehydrochloride;Ancoron;Angiodarona;Cordarex;Cordarone;L 3428;Miocard;Ortacrone;Ritmocardyl;Trangorex;
- EINECS:
- 243-293-2
- Boiling Point:
- 635.1 °C at 760 mmHg
- Flash Point:
- 337.9 °C
- Hazard Symbols:
Xn- Risk Codes:
- 20/21/22
- Safety Description:
- 36 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Specification
The IUPAC name of Amiodarone hydrochloride is (2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone hydrochloride. With the CAS registry number 19774-82-4, it is also named as Miodrone. The product's categories are Active Pharmaceutical Ingredients; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; API's; Ion transporter and other ion Channel. It should be stored at 2-8 °C. Besides, this chemical is antianginal and antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting Na,K-activated myocardial adenosine triphosphatase. In addition, its molecular formula is C25H30ClI2NO3 and molecular weight is 681.78.
The other characteristics of Amiodarone hydrochloride can be summarized as: (1)EINECS: 243-293-2; (2)ACD/LogP: 8.89; (3)# of Rule of 5 Violations: 2; (4)ACD/LogD (pH 5.5): 5.86; (5)ACD/LogD (pH 7.4): 6.94; (6)ACD/BCF (pH 5.5): 3126.06; (7)ACD/BCF (pH 7.4): 38076.16; (8)ACD/KOC (pH 5.5): 1518.66; (9)ACD/KOC (pH 7.4): 18497.71; (10)#H bond acceptors: 4; (11)#H bond donors: 0; (12)#Freely Rotating Bonds: 11; (13)Polar Surface Area: 39.44 Å2; (14)Flash Point: 337.9 °C; (15)Enthalpy of Vaporization: 93.85 kJ/mol; (16)Boiling Point: 635.1 °C at 760 mmHg; (17)Vapour Pressure: 4.95E-16 mmHg at 25 °C.
When you are using this chemical, please be cautious about it as the following: it is harmful by inhalation, in contact with skin and if swallowed. You should wear suitable protective clothing.
People can use the following data to convert to the molecule structure.
(1)SMILES: [Cl-].Ic1cc(cc(I)c1OCC[NH+](CC)CC)C(=O)c2c3ccccc3oc2CCCC
(2)InChI: InChI=1/C25H29I2NO3.ClH/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3;/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3;1H
(3)InChIKey: ITPDYQOUSLNIHG-UHFFFAOYAF
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | intravenous | 5gm/kg (5000mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
| dog | LD50 | oral | > 5gm/kg (5000mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
| man | LDLo | oral | 3129mg/kg/3Y- (3129mg/kg) | LUNGS, THORAX, OR RESPIRATION: PLEURAL THICKENING LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Southern Medical Journal. Vol. 89, Pg. 85, 1996. |
| man | TDLo | oral | 171mg/kg/30D- (171mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | American Heart Journal. Vol. 100, Pg. 412, 1980. |
| man | TDLo | oral | 240mg/kg/6W-I (240mg/kg) | SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Archives of Internal Medicine. Vol. 155, Pg. 1106, 1995. |
| mouse | LD50 | intraperitoneal | 450mg/kg (450mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
| mouse | LD50 | oral | > 3gm/kg (3000mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
| rat | LD50 | intraperitoneal | 610mg/kg (610mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
| rat | LD50 | intravenous | 170mg/kg (170mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
| rat | LD50 | oral | > 3gm/kg (3000mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
| women | TDLo | oral | 120mg/kg/10D- (120mg/kg) | CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) | Human Toxicology. Vol. 4, Pg. 169, 1985. |
| women | TDLo | oral | 1128mg/kg/56W (1128mg/kg) | LUNGS, THORAX, OR RESPIRATION: "FIBROSIS, FOCAL (PNEUMOCONIOSIS)" LUNGS, THORAX, OR RESPIRATION: DYSPNEA | American Journal of Medicine. Vol. 86, Pg. 134, 1989. |
| women | TDLo | oral | 2480mg/kg/43W (2480mg/kg) | ENDOCRINE: THYROID WEIGHT (GOITER) | Acta Medica Scandinavica. Vol. 221, Pg. 219, 1987. |

